Frontlight ResearchEarly access
Taking peoplePhase 1
NON-IV: Neo-adjuvant peritumOral immuNotherapy In Vulvar cancer
Key facts
- Who runs it
- Amsterdam UMC Stichting
- Where
- Netherlands2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 24 people, planned
- Started
- 4 Feb 2026
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional
- Record updated
- 16 December 2025
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Vulvar cancer
This trial is currently available in Netherlands.
It has sites in one country. Choose a country to see its sites.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
Download the PDF
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Criteria questions
- Built from 2025-520712-34-00, who can take part
- Record updated
- 16 December 2025